|
1
|
Zimmet P, Alberti KG and Shaw J: Global
and societal implications of the diabetes epidemic. Nature.
414:782–787. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tsai TY, Cheng JF and Lai YM: Prevalence
of metabolic syndrome and related factors in Taiwanese high-tech
industry workers. Clinics (Sao Paulo). 66:1531–1535. 2011.
View Article : Google Scholar
|
|
3
|
Maria Rotella C, Pala L and Mannucci E:
Role of insulin in the type 2 diabetes therapy: Past, present and
future. Int J Endocrinol Metab. 11:137–144. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Krone CA and Ely JT: Controlling
hyperglycemia as an adjunct to cancer therapy. Integr Cancer Ther.
4:25–31. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stattin P, Björ O, Ferrari P, Lukanova A,
Lenner P, Lindahl B, Hallmans G and Kaaks R: Prospective study of
hyperglycemia and cancer risk. Diabetes Care. 30:561–567. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hsieh MC, Lee TC, Cheng SM, Tu ST, Yen MH
and Tseng CH: The influence of type 2 diabetes and glucose-lowering
therapies on cancer risk in the Taiwanese. Exp Diabetes Res.
2012:4137822012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Beckner ME, Stracke ML, Liotta LA and
Schiffmann E: Glycolysis as primary energy source in tumor cell
chemotaxis. J Natl Cancer Inst. 82:1836–1840. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Heuson JC and Legros N: Influence of
insulin deprivation on growth of the
7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats
subjected to alloxan diabetes and food restriction. Cancer Res.
32:226–232. 1972.PubMed/NCBI
|
|
9
|
Masur K, Vetter C, Hinz A, Tomas N,
Henrich H, Niggemann B and Zänker KS: Diabetogenic glucose and
insulin concentrations modulate transcriptome and protein levels
involved in tumour cell migration, adhesion and proliferation. Br J
Cancer. 104:345–352. 2011. View Article : Google Scholar
|
|
10
|
Giovannucci E, Harlan DM, Archer MC,
Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG and
Yee D: Diabetes and cancer: A consensus report. CA Cancer J Clin.
60:207–221. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Will JC, Galuska DA, Vinicor F and Calle
EE: Colorectal cancer: Another complication of diabetes mellitus?
Am J Epidemiol. 147:816–825. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Saydah SH, Platz EA, Rifai N, Pollak MN,
Brancati FL and Helzlsouer KJ: Association of markers of insulin
and glucose control with subsequent colorectal cancer risk. Cancer
Epidemiol Biomarkers Prev. 12:412–418. 2003.PubMed/NCBI
|
|
13
|
Giovannucci E: Insulin, insulin-like
growth factors and colon cancer: A review of the evidence. J Nutr.
131(Suppl): 3109S–3120S. 2001.PubMed/NCBI
|
|
14
|
Zhang H, Pelzer AM, Kiang DT and Yee D:
Down-regulation of type I insulin-like growth factor receptor
increases sensitivity of breast cancer cells to insulin. Cancer
Res. 67:391–397. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dinchuk JE, Cao C, Huang F, Reeves KA,
Wang J, Myers F, Cantor GH, Zhou X, Attar RM, Gottardis M, et al:
Insulin receptor (IR) pathway hyperactivity in IGF-IR null cells
and suppression of downstream growth signaling using the dual
IGF-IR/IR inhibitor, BMS-754807. Endocrinology. 151:4123–4132.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo H, Gao M, Lu Y, Liang J, Lorenzi PL,
Bai S, Hawke DH, Li J, Dogruluk T, Scott KL, et al: Coordinate
phosphorylation of multiple residues on single AKT1 and AKT2
molecules. Oncogene. 33:3463–3472. 2014. View Article : Google Scholar :
|
|
17
|
Ericson K, Gan C, Cheong I, Rago C,
Samuels Y, Velculescu VE, Kinzler KW, Huso DL, Vogelstein B and
Papadopoulos N: Genetic inactivation of AKT1, AKT2, and PDPK1 in
human colorectal cancer cells clarifies their roles in tumor growth
regulation. Proc Natl Acad Sci USA. 107:2598–2603. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Strober W: Trypan blue exclusion test of
cell viability. Curr Protoc Immunol. 111:A3.B.1–3. 2015. View Article : Google Scholar
|
|
19
|
Fukazawa H, Mizuno S and Uehara Y: A
microplate assay for quantitation of anchorage-independent growth
of transformed cells. Anal Biochem. 228:83–90. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Folkman J and Moscona A: Role of cell
shape in growth control. Nature. 273:345–349. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lu CC, Yang SH, Hsia SM, Wu CH and Yen GC:
Inhibitory effects of Phyllanthus emblica L. on hepatic steatosis
and liver fibrosis in vitro. J Funct Foods. 20:20–30. 2016.
View Article : Google Scholar
|
|
22
|
Lu CC, Yang JS, Chiang JH, Hour MJ,
Amagaya S, Lu KW, Lin JP, Tang NY, Lee TH and Chung JG: Inhibition
of invasion and migration by newly synthesized quinazolinone MJ-29
in human oral cancer CAL 27 cells through suppression of MMP-2/9
expression and combined down-regulation of MAPK and AKT signaling.
Anticancer Res. 32:2895–2903. 2012.PubMed/NCBI
|
|
23
|
Lu CC, Yang JS, Huang AC, Hsia TC, Chou
ST, Kuo CL, Lu HF, Lee TH, Wood WG and Chung JG: Chrysophanol
induces necrosis through the production of ROS and alteration of
ATP levels in J5 human liver cancer cells. Mol Nutr Food Res.
54:967–976. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kitabchi AE, Umpierrez GE, Miles JM and
Fisher JN: Hyper-glycemic crises in adult patients with diabetes.
Diabetes Care. 32:1335–1343. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Barone BB, Yeh HC, Snyder CF, Peairs KS,
Stein KB, Derr RL, Wolff AC and Brancati FL: Long-term all-cause
mortality in cancer patients with preexisting diabetes mellitus: A
systematic review and meta-analysis. JAMA. 300:2754–2764. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lawlor MA and Alessi DR: PKB/Akt: A key
mediator of cell proliferation, survival and insulin responses? J
Cell Sci. 114:2903–2910. 2001.PubMed/NCBI
|
|
27
|
Le Marchand L, Wilkens LR, Kolonel LN,
Hankin JH and Lyu LC: Associations of sedentary lifestyle, obesity,
smoking, alcohol use, and diabetes with the risk of colorectal
cancer. Cancer Res. 57:4787–4794. 1997.PubMed/NCBI
|
|
28
|
Kono S, Honjo S, Todoroki I, Nishiwaki M,
Hamada H, Nishikawa H, Koga H, Ogawa S and Nakagawa K: Glucose
intolerance and adenomas of the sigmoid colon in Japanese men
(Japan). Cancer Causes Control. 9:441–446. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Barnea M, Madar Z and Froy O: Glucose and
insulin are needed for optimal defensin expression in human cell
lines. Biochem Biophys Res Commun. 367:452–456. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Matthews DR, Hosker JP, Rudenski AS,
Naylor BA, Treacher DF and Turner RC: Homeostasis model assessment:
Insulin resistance and beta-cell function from fasting plasma
glucose and insulin concentrations in man. Diabetologia.
28:412–419. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ayiomamitis GD, Notas G, Zaravinos A,
Drygiannakis I, Georgiadou M, Sfakianaki O, Mastrodimou N, Thermos
K and Kouroumalis E: Effects of octreotide and insulin on colon
cancer cellular proliferation and correlation with hTERT activity.
Oncoscience. 1:457–467. 2014. View Article : Google Scholar
|
|
32
|
DeBerardinis RJ, Lum JJ, Hatzivassiliou G
and Thompson CB: The biology of cancer: Metabolic reprogramming
fuels cell growth and proliferation. Cell Metab. 7:11–20. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lv L, Xu YP, Zhao D, Li FL, Wang W, Sasaki
N, Jiang Y, Zhou X, Li TT, Guan KL, et al: Mitogenic and oncogenic
stimulation of K433 acetylation promotes PKM2 protein kinase
activity and nuclear localization. Mol Cell. 52:340–352. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Duan W, Shen X, Lei J, Xu Q, Yu Y, Li R,
Wu E and Ma Q: Hyperglycemia, a neglected factor during cancer
progression. BioMed Res Int. 2014:4619172014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Saltiel AR and Pessin JE: Insulin
signaling pathways in time and space. Trends Cell Biol. 12:65–71.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang H, Fagan DH, Zeng X, Freeman KT,
Sachdev D and Yee D: Inhibition of cancer cell proliferation and
metastasis by insulin receptor downregulation. Oncogene.
29:2517–2527. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lau MT and Leung PC: The PI3K/Akt/mTOR
signaling pathway mediates insulin-like growth factor 1-induced
E-cadherin down-regulation and cell proliferation in ovarian cancer
cells. Cancer Lett. 326:191–198. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ulanet DB, Ludwig DL, Kahn CR and Hanahan
D: Insulin receptor functionally enhances multistage tumor
progression and conveys intrinsic resistance to IGF-1R targeted
therapy. Proc Natl Acad Sci USA. 107:10791–10798. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jiang BH and Liu LZ: PI3K/PTEN signaling
in tumorigenesis and angiogenesis. Biochim Biophys Acta.
1784:150–158. 2008. View Article : Google Scholar
|
|
40
|
Dancey J: mTOR signaling and drug
development in cancer. Nat Rev Clin Oncol. 7:209–219. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Laplante M and Sabatini DM: mTOR signaling
in growth control and disease. Cell. 149:274–293. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yang K, Guo Y, Stacey WC, Harwalkar J,
Fretthold J, Hitomi M and Stacey DW: Glycogen synthase kinase 3 has
a limited role in cell cycle regulation of cyclin D1 levels. BMC
Cell Biol. 7:332006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Takahashi-Yanaga F and Sasaguri T:
GSK-3beta regulates cyclin D1 expression: A new target for
chemotherapy. Cell Signal. 20:581–589. 2008. View Article : Google Scholar
|
|
44
|
Maddocks OD and Vousden KH: Metabolic
regulation by p53. J Mol Med (Berl). 89:237–245. 2011. View Article : Google Scholar
|
|
45
|
Sarfstein R, Friedman Y, Attias-Geva Z,
Fishman A, Bruchim I and Werner H: Metformin downregulates the
insulin/IGF-I signaling pathway and inhibits different uterine
serous carcinoma (USC) cells proliferation and migration in
p53-dependent or -independent manners. PLoS One. 8:e615372013.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zawacka-Pankau J, Issaeva N, Hossain S,
Pramanik A, Selivanova G and Podhajska AJ: Protoporphyrin IX
interacts with wild-type p53 protein in vitro and induces cell
death of human colon cancer cells in a p53-dependent and
-independent manner. J Biol Chem. 282:2466–2472. 2007. View Article : Google Scholar
|
|
47
|
Zhang W and Liu HT: MAPK signal pathways
in the regulation of cell proliferation in mammalian cells. Cell
Res. 12:9–18. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wada T and Penninger JM: Mitogen-activated
protein kinases in apoptosis regulation. Oncogene. 23:2838–2849.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Huang C, Jacobson K and Schaller MD: MAP
kinases and cell migration. J Cell Sci. 117:4619–4628. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Liao DJ, Thakur A, Wu J, Biliran H and
Sarkar FH: Perspectives on c-Myc, Cyclin D1, and their interaction
in cancer formation, progression, and response to chemotherapy.
Crit Rev Oncog. 13:93–158. 2007. View Article : Google Scholar
|
|
51
|
Lu Z, Lu N, Li C, Li F, Zhao K, Lin B and
Guo Q: Oroxylin A inhibits matrix metalloproteinase-2/9 expression
and activation by up-regulating tissue inhibitor of
metalloproteinase-2 and suppressing the ERK1/2 signaling pathway.
Toxicol Lett. 209:211–220. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Qi HL, Zhang Y, Ma J, Guo P, Zhang XY and
Chen HL: Insulin/protein kinase B signalling pathway upregulates
metastasis-related phenotypes and molecules in H7721 human
hepatocarcinoma cell line. Eur J Biochem. 270:3795–3805. 2003.
View Article : Google Scholar : PubMed/NCBI
|
